MetaVia Inc. – Filings and Transcripts

NASDAQ: MTVA
Share price (10/16/26): $1.26
Market cap (10/16/26): $8.301 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Registration of securities for employees

Prospectus supplement

Registration of securities for employees

Updated info for already-effective prospectus

Ownership Filter

Browne Sarah Kaplan

Browne Sarah Kaplan

Tursi James Patrick

Strickland D Gordon

Salsbury Michael

News Filter

Appoints Seasoned Clinical Development Executive Sarah Browne, M.D., as Chief Medical Officer

Announces Preclinical Findings Supporting Biological Rationale for DA-1726's Waist Circumference Reduction

Reports Second Quarter 2026 Financial Results and Provides Corporate Update

Announces Completion of Dose Titration in Phase 1 Part 3 Study of DA-1726 for the Treatment of Obesity

Other Events, Financial Statements or Exhibits

Proxies Filter

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Definitive proxy

Other Filter

Scanned paper annual report submission

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Correspondence with the SEC